The company will use proceeds of the fundraising round to complete its ongoing Phase 1B trial on low-dose psilocybin in patients suffering from a rare headache condition with no approved medications to treat it.
A nasal spray of ketamine proved to be highly effective at treating a type of migraine called refractory migraines, according to a new study.
Psilocybin is showing relief as treatment for cluster headaches — a painful condition that affects more than 300,000 Americans a year.
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.